menu search

U.s. fda approves amgen's biosimilar vesrion of j&j's stelara

The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster ...

October 31, 2023, 6:32 pm

Bristol myers says it needs another year to hit target for new drugs

Drugmaker Bristol Myers Squibb on Thursday pushed back by a year the time frame for its current new-product portfolio to hit $10 billion in sales as t...

October 26, 2023, 7:02 am

Evelo (evlo) drops 59% on flunking psoriasis drug study

Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis...

October 18, 2023, 12:47 pm

Evelo biosciences shares tank 46% after trial failure

Evelo Biosciences' shares have tumbled 46% in premarket trading after the biotech firm revealed disappointing results in a phase II ...

October 17, 2023, 9:00 am

Arcutis (arqt) up on fda nod for zoryve label expansion

Arcutis (ARQT) gains on receiving FDA approval for label expansion of Zoryve (roflumilast) cream 0.3% to treat patients in the age group of 6-11 years...

October 9, 2023, 10:31 am

Moonlake immunotherapeutics is now thoroughly de-risked

MoonLake Immunotherapeutics has seen success in the last 5 months after positive data from a phase 2 trial of sonelokimab in hidradenitis suppurativa....

September 27, 2023, 8:00 pm

Protagonist therapeutics: there are reasons behind johnson & johnson's optimism

Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior effica...

September 22, 2023, 3:35 pm

Sandoz enters commercialisation agreement with samsung bioepis

Swiss drugmaker Sandoz said on Monday that it had entered into an agreement with Samsung Bioepis giving it exclusive rights to commercialise the ...

September 11, 2023, 1:40 am

Merck, amgen, abbvie products among first 10 drugs selected for medicare price negotiations

Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implica...

August 29, 2023, 7:50 am

Evelo biosciences: may be worth a small, highly speculative long position considering upcoming psoriasis phase 2 results

Following recent cash raise, EVLO has enough (barely) cash to the next catalyst, phase 2 readout in psoriasis<...

August 25, 2023, 5:08 pm

Why shares of roivant sciences rose wednesday

Roivant saw improved revenue and EPS in the fourth quarter. The company's lead therapy is plaque psoriasis...

June 28, 2023, 3:47 pm

Why shares of arcutis biotherapeutics jumped this week

Arcutis Biotherapeutics launched roflumilast in a cream form last summer to treat plaque psoriasis. The...

June 9, 2023, 5:33 pm

Analysis: stelara patent deal puts j&j back on path to $57 bln 2025 revenue forecast

Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis...

June 5, 2023, 6:15 am

Dice therapeutics psoriasis treatment has blockbuster potential, analysts say

Canaccord Genuity (TSX:CF, LSE:CF) analysts have initiated coverage of DICE Therapeutics, Inc, a biopharmaceutical company focused on treating chronic...

May 23, 2023, 2:56 pm

Reviva pharmaceuticals announces intent to file an ind for brilaroxazine in psoriasis after promising preclinical data

Brilaroxazine topical liposomal-gel formulation (brilaroxazine lipogel) demonstrated proof-of-concept efficacy in the imiquimod-induced psoriatic mous...

May 11, 2023, 10:30 am

Protagonist, a top 1% biotech, briefly breaks out on psoriasis enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its ...

May 5, 2023, 11:58 am

Evelo biosciences provides clinical updates

– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on developme...

April 26, 2023, 11:30 am

Amgen (amgn) wins patent appeal for blockbuster psoriasis drug

The Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug Otezla ...

April 20, 2023, 9:56 am

Bristol myers (bmy) gets approval of psoriasis drug in eu

Bristol Myers' (BMY) Sotyktu gets approval from the European Commission to treat adults with moderate-to-severe plaque ...

March 28, 2023, 4:45 pm

Roivant stock pops after positive topline results for its vtama cream from the adoring 2 atopic dermatitis phase 3 trial

Roivant Sciences Limited saw its shares rise after its subsidiary Dermavant Sciences reported positive topline results from ADORING 2, one of two Phas...

March 15, 2023, 12:34 pm


Search within

Pages Search Results: